Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
(for at least one location)
Describes the nature of a clinical study. Types include:
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS), in addition to the standard National Cancer Institute's Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score, will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer.
Study statuses change often. Please contact us for help.
Closed for enrollment
Rochester, MN, Scottsdale/Phoenix, AZ, Jacksonville, FL
A group of doctors and scientists led by Dr. Fergus Couch at the Mayo Clinic in Rochester, Minnesota, are conducting this study to advance our understanding of how breast cancer is inherited through families. Genetic testing of breast cancer genes is often done to find the cause of breast cancer tracking through families. Testing often identifies deleterious (cancer causing) mutations and Variants of Uncertain Significance (VUS), that may or may not cause breast cancer. Because of uncertainties about the meaning of many of these results, patients and their family members often cannot benefit from the knowledge that they have one of these mutations. In this study we aim to establish the risks of cancer for deleterious mutations and VUS in each of the clinically tested breast cancer genes, so that families and their health care providers can better manage their risk of breast cancer. To answer these questions, we plan to use mutation results from genes currently included on genetic testing panels for breast cancer, along with information on the history of cancer in families and on breast cancer risk factors collected using a questionnaire.
Open for enrollment
Contact us for the latest status
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.